Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, September 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs: 7 blogs
policy: 1 policy source
twitter: 148 tweeters

facebook: 6 Facebook pages
wikipedia: 2 Wikipedia pages
googleplus: 3 Google+ users

Citations

dimensions_citation: 168 Dimensions

Readers on

mendeley: 400 Mendeley
citeulike: 3 CiteULike

Summary Blogs Policy documents Twitter Facebook Wikipedia Google+ Dimensions citations

So far, Dimensions has found 168 publications that cite this research output.

168

The most recent citing publications are shown below. View all 168 publications that cite this research output on Dimensions.

Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease (COPD) exacerbation: attitudes of patients and healthcare providers in the COVID-19 era.

Article in Journal of Asthma (May 2022)

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

Article in Advances in Therapy (March 2022)

Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’

Article in Respirology (February 2022)